These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8996734)
1. Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Nomura S; Hanaki H; Furukawa T; Unemi N Chemotherapy; 1997; 43(1):1-5. PubMed ID: 8996734 [TBL] [Abstract][Full Text] [Related]
2. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae]. Fukuoka T; Inoue H; Abe T; Ohya S Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055 [TBL] [Abstract][Full Text] [Related]
3. [The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture]. Ishigo S; Tamaya T; Matsubara S; Suematsu H; Sawamura H; Matsukawa Y; Hashido H; Iwata I; Mikamo H Jpn J Antibiot; 2000 Dec; 53(12):652-9. PubMed ID: 11234221 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem. Hupková H; Trupl J Folia Microbiol (Praha); 1998; 43(1):68-70. PubMed ID: 9569631 [TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Nomura S; Hanaki H; Unemi N Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis. Nomura S; Hanaki H; Furukawa T; Unemi N Chemotherapy; 1996; 42(6):432-8. PubMed ID: 8957577 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511 [TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae]. Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. Reinert RR; Al-Lahham A; Lütticken R J Antimicrob Chemother; 2001 Aug; 48(2):279-81. PubMed ID: 11481301 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia. Urbásková P; Trupl J; Hupková H; Appelbaum PC; Jacobs MR Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):686-8. PubMed ID: 8894582 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Yee YC; Thornsberry C; Brown SD; Bouchillon SK; Marler JK; Rich T J Antimicrob Chemother; 1993 Nov; 32 Suppl B():13-9. PubMed ID: 8150756 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic sensitivity pattern of pneumococci relatively insensitive to penicillin and cephalosporin antibiotics. Hansman D Med J Aust; 1975 Nov; 2(19):740-2. PubMed ID: 2851 [TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone. Bell SM; Gatus BJ; Pham JN Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145 [No Abstract] [Full Text] [Related]
16. Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone. Kim JH; Kang JA; Lee Y; Lee KH; Lee JH; Choi EC; Kim BK J Antimicrob Chemother; 1998 Oct; 42(4):527-30. PubMed ID: 9818754 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis. Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae. Traub WH; Leonhard B Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790 [TBL] [Abstract][Full Text] [Related]
19. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci. Li J; Zhang Y; Chen Y; Hao F; Chen Y Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034 [TBL] [Abstract][Full Text] [Related]
20. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model. Cappelletty DM; Rybak MJ Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]